Skip to main content
. 2015 Mar 23;10(3):e0121112. doi: 10.1371/journal.pone.0121112

Fig 1. Serum marker levels for sample set 1.

Fig 1

(a) The levels of CA125, and LRG1 were examined in the serum from healthy controls, surgical controls, benign diseases, stage I/II EOC, and stage III /IV EOC. *p<0.05 indicates a significant difference between pairwise comparisons (all cases vs. all controls; early stage cases vs. all controls; late stage cases vs. all controls). (b) Marker distributions for the EOC patients from sample set 1 with different histological subtypes.